Disclosures under Reg. 30 of the Listing Regulations

2024

Disclosures under Reg. 30 of the Listing Regulations 2024

Announcement under Regulation 30 (Nov 2024)

Change in Sr. Management (PDF • Nov 2024)

Announcement under Regulation 30 (PDF • June 2024)

Announcement under Regulation 30 (PDF • March 2024)

Announcement under Regulation 30 (PDF • Feb 2024)

Announcement under Regulation 30 (PDF • Jan 2024)

Change in Key Managerial Personnel (September 2024)

Announcement under Regulation 30 (PDF • Aug 2024)

Change in Sr. Management (PDF • June 2024)

Change in Directorate (PDF • May 2024)

Announcement under Regulation 30 (PDF • May 2024)

Announcement under Regulation 30 (PDF • March 2024 )

2023

Disclosures under Reg. 30 of the Listing Regulations 2023

Announcement under Regulation 30 (PDF )

Change in Sr. Management (PDF)

Announcement under Regulation 30 (PDF )

Reg 30 - Press Release by promoter Company (PDF )

Change in Directorate (PDF • September 2023 )

Change in Directorate (PDF • September 2023 )

Observation letters from BSE and NSE for the Scheme of Demerger (PDF • September 2023)

Change in Sr. Management (PDF • September 2023 )

Reg 30 – Pending Litigation (PDF • August 2023 )

Change in Sr. Management (PDF • August 2023 )

Resignation of Director (PDF • June 2023 )

Presentation of Investor/Analyst call May 2023 (PDF • May 2023 )

Reg 30 Scheme of arrangement (PDF • May 2023 )

Intimation for Investor / Analysts Call – May 2023 (PDF • May 2023 )

Announcement Under Regulation 30 - NLEM Communication (PDF • April 2023)

Investor / Analyst Meet Transcript 24.02.2023 (PDF • Feb 2023 )

Presentation for Investor / Analyst call – Feb 2023 (PDF • 2023-02-24 )

Intimation for Investor / Analysts Call (PDF • 2023-02-16)

Recording of Investor / Analyst Call - May 2023

Video • May 2023

2022

Disclosures under Reg. 30 of the Listing Regulations 2022

Announcement under Regulation 30 (LODR)-Change in Directorate (PDF • 2022-03-11 )

Reg 30 anouncement - NSE BSE NLEM (PDF • 2022-09-16)

Authorized officials for disclosure of Material information to Stock Exchange (PDF • 2022-06-01 )

Intimation for Investor Call (PDF • 2022-02-23 )

Resignation of Managing Director (PDF • 2022-01-13 )

2021

Disclosures under Reg. 30 of the Listing Regulations 2021

Divestment of Soframycin® and Sofradex® businesses (PDF • November 26, 2021 )

Resignation of Non-Executive Director (PDF • November 24, 2021 )

Appointment of Company Secretary and change in Compliance Officer (PDF • October 27, 2021 )

Resignation of Company Secretary (Key Managerial Personnel) & Change in Compliance Officer (PDF • August 13, 2021)

Slump Sale and transfer of the Nutraceuticals business of the Company (PDF • July 28, 2021 )

Investor Webinar Presentation (PDF • March 17, 2021 )

Intimation for Investor Webinar on 17th March 2021 (PDF • February 24, 2021 )

Appointment / Re-appointment of Directors, Re-appointment of Chairman (PDF • February 24, 2021 )

2020

Disclosures under Reg. 30 of the Listing Regulations 2020

Authorized officials for disclosure of material information to Stock Exchanges (PDF • October 06, 2020 )

Appointment of Chief Financial Officer (PDF • October 05, 2020 )

Resignation of Whole Time Director & Chief Financial Officer (PDF • September 16, 2020 )

Disclosure on Impact of COVID-19 (PDF • July 28, 2020 )

2019

Disclosures under Reg. 30 of the Listing Regulations 2019

Outcome of Board Meeting held on 10th September 2019 (PDF • September 11, 2019 )

Resignation of Whole Time Director (PDF • May 7, 2019 )

Clarification on the media report in ‘The Hindu’ (PDF • February 19, 2019)

2018

Disclosures under Reg. 30 of the Listing Regulations 2018

Clarification on the media report in the Indian Express (PDF • November 13, 2018)

Change in Chief Financial Officer (PDF • May 09, 2018)

2015

Disclosures under Reg. 30 of the Listing Regulations 2015

Disclosure under Regulation 30(5) of LODR 2015 - 10.12.2015 (PDF • 2016-01-12)